Recursion Pharmaceuticals Stock

Recursion Pharmaceuticals Interest Expense

Interest Expense of Recursion Pharmaceuticals (RXRX) as of Jul 30, 2026.

Interest Expense

0.00USD

Last updated:

Interest Expense of Recursion Pharmaceuticals is 2026 0.00 USD. Interest Expense of Recursion Pharmaceuticals was 2025 14.19 M USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Recursion Pharmaceuticals Stock analysis

What does Recursion Pharmaceuticals do? Recursion Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Recursion Pharmaceuticals stock

On Eulerpool you can find the complete historical development of Interest Expense Recursion Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Access this data via the Eulerpool API

Income Statement — Recursion Pharmaceuticals

All Key Metrics — Recursion Pharmaceuticals